Literature DB >> 8782145

Clinical features of patients with juvenile onset mixed connective tissue disease: analysis of data collected in a nationwide collaborative study in Japan.

L Kotajima1, S Aotsuka, M Sumiya, R Yokohari, T Tojo, R Kasukawa.   

Abstract

OBJECTIVE: To analyze the clinical features and outcome of juvenile-onset mixed connective tissue disease (MCTD).
METHODS: Clinical and laboratory findings were compared in 2 groups of MCTD patients divided according to age at onset: juvenile onset: under 16 yrs: adult onset: 16 yrs or older).
RESULTS: Systemic lupus erythematosus-like symptoms, such as facial erythema, photosensitivity. LE cells, lymphadenopathy, and cellular casts, were more frequent in juvenile onset MCTD than in the adult form of the disease. On the other hand, scleroderma-like symptoms, such as esophageal hypomotility, scleroderma-like lesions evident on skin biopsy, pulmonary involvement, proximal scleroderma, and pitting scars, were less frequent in juvenile onset MCTD than in the adult form. Patients with juvenile onset MCTD more frequently met the classification criteria for systemic lupus erythematosus (SLE) and less frequently met those for progressive systemic sclerosis (SSc), compared to patients with adult onset MCTD. At disease onset, hand edema and stiffness were observed less frequently in juvenile onset MCTD than in the adult form. Furthermore, the mortality rate was lower in the former than in the latter (2.8% vs 8.4%).
CONCLUSION: Although previous studies have reported severe symptoms and adverse outcome for juvenile onset MCTD, we conclude from this nationwide study in Japan that patients with juvenile onset MCTD exhibit more SLE-like and fewer SSc-like features and have a relatively favorable outcome.

Entities:  

Mesh:

Year:  1996        PMID: 8782145

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  7 in total

Review 1.  Taxonomy for systemic lupus erythematosus with onset before adulthood.

Authors:  Clovis A Silva; Tadej Avcin; Hermine I Brunner
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-12       Impact factor: 4.794

2.  Elevated immunoglobulin G antibodies to the proline-rich amino-terminal region of Epstein-Barr virus nuclear antigen-2 in sera from patients with systemic connective tissue diseases and from a subgroup of Sjögren's syndrome patients with pulmonary involvements.

Authors:  M Yamazaki; R Kitamura; S Kusano; H Eda; S Sato; M Okawa-Takatsuji; S Aotsuka; K Yanagi
Journal:  Clin Exp Immunol       Date:  2005-03       Impact factor: 4.330

Review 3.  Pediatric Mixed Connective Tissue Disease.

Authors:  Roberta A Berard; Ronald M Laxer
Journal:  Curr Rheumatol Rep       Date:  2016-05       Impact factor: 4.592

4.  Fifteen-year experience of pediatric-onset mixed connective tissue disease.

Authors:  Yi-Ying Tsai; Yao-Hsu Yang; Hsin-Hui Yu; Li-Chieh Wang; Jyh-Hong Lee; Bor-Luen Chiang
Journal:  Clin Rheumatol       Date:  2009-09-16       Impact factor: 2.980

5.  Clinical and immunologic manifestations of mixed connective tissue disease in a Miami population compared to a Midwestern US Caucasian population.

Authors:  Marcos E Maldonado; Magdalena Perez; Judith Pignac-Kobinger; Emily Triana Marx; Elaine M Tozman; Eric L Greidinger; Robert W Hoffman
Journal:  J Rheumatol       Date:  2008-02-01       Impact factor: 4.666

6.  Capillaroscopy as a diagnostic tool in the diagnosis of mixed connective tissue disease (MCTD): a case report.

Authors:  Mislav Radić; Rebecca S Overbury
Journal:  BMC Rheumatol       Date:  2021-03-19

7.  Clinical features and outcome of mixed connective tissue disease in developmental age - observational study from one center.

Authors:  Lidia Rutkowska-Sak; Piotr Gietka
Journal:  Reumatologia       Date:  2019-12-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.